4.8 Editorial Material

SnapShot: The Intestinal Crypt

期刊

CELL
卷 152, 期 5, 页码 1198-+

出版社

CELL PRESS
DOI: 10.1016/j.cell.2013.02.030

关键词

-

资金

  1. ICREA Funding Source: Custom

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population

Hiroaki Kasashima, Angeles Duran, Anxo Martinez-Ordonez, Yuki Nakanishi, Hiroto Kinoshita, Juan F. Linares, Miguel Reina-Campos, Yotaro Kudo, Antoine L'Hermitte, Masakazu Yashiro, Masaichi Ohira, Fei Bao, Daniele V. F. Tauriello, Eduard Batlle, Maria T. Diaz-Meco, Jorge Moscat

Summary: The upregulation of SOX2 plays a central role in the acquisition of the CAF phenotype, which is repressed by PKC zeta. The PKC zeta-SOX2 axis is crucial in controlling the pro-tumorigenic potential of CAFs, as loss of SOX2 or Sfrp1/2 in CAFs impairs the migration, invasion, and tumorigenicity of colon cancer cells. High stromal levels of PKC zeta and SOX2 expression in the stroma are associated with worse prognoses in colorectal cancer patients.

DEVELOPMENTAL CELL (2021)

Article Multidisciplinary Sciences

Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development

Annarita Sibilio, Clara Suner, Marcos Fernandez-Alfara, Judit Martin, Antonio Berenguer, Alexandre Calon, Veronica Chanes, Alba Millanes-Romero, Gonzalo Fernandez-Miranda, Eduard Batlle, Mercedes Fernandez, Raul Mendez

Summary: This study investigates the role of the RNA-binding protein CPEB4 in intestinal immune homeostasis and its contribution to the development of inflammatory bowel diseases and colorectal cancer. The researchers found that CPEB4 is expressed in the intestines after damage and is necessary for the translation of cytokine mRNA, such as interleukin-22. It plays a role in maintaining intestinal immune homeostasis, promoting repair and remodeling after tissue damage, and resolving inflammation. Chronic overexpression of CPEB4 is observed in inflammatory cells in patients with IBD and CRC, which promotes tumor development.

ISCIENCE (2022)

Article Immunology

Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3-and B7H4-dependent anti-tumor immunity in colorectal cancer

Kenneth Peuker, Anne Strigli, Daniele V. F. Tauriello, Alexander Hendricks, Witigo von Schonfels, Greta Burmeister, Mario Brosch, Alexander Herrmann, Sandra Krueger, Jessica Nitsche, Lea Juznic, Marc Marius Geissler, Andreas Hiergeist, Andre Gessner, Jakob Wirbel, Ruby Priyadarshini Ponnudurai, Antje Tunger, Rebekka Wehner, Daniel E. Stange, Juergen Weitz, Daniela E. Aust, Gustavo B. Baretton, Marc Schmitz, Christoph Rocken, Jochen Hampe, Sebastian Hinz, Georg Zeller, Triantafyllos Chavakis, Clemens Schafmayer, Eduard Batlle, Sebastian Zeissig

Summary: Bacterial sensing by intestinal tumor cells contributes to tumor growth through the calcineurin-NFAT axis, while its inhibition can activate CD8(+) T cell responses and inhibit colorectal cancer growth. This pathway also controls the expression of B7H3 and B7H4 by tumor cells, which inhibits CD8(+) T cell-dependent anti-tumor immunity.

IMMUNITY (2022)

Article Pathology

Epigenome-Wide DNA Methylation Profiling of Normal Mucosa Reveals HLA-F Hypermethylation as a Biomarker Candidate for Serrated Polyposis Syndrome

Gerhard Jung, Eva Hernandez-Illan, Juan J. Lozano, Julia Sidorova, Jenifer Munoz, Yasuyuki Okada, Enrique Quintero, Goretti Hernandez, Rodrigo Jover, Sabela Carballal, Miriam Cuatrecasas, Lorena Moreno, Mireia Diaz, Teresa Ocana, Ariadna Sanchez, Liseth Rivero, Oswaldo Ortiz, Joan Llach, Antoni Castells, Maria Pellise, Ajay Goel, Eduard Batlle, Francesc Balaguer

Summary: Serrated polyposis syndrome (SPS) is associated with a high risk for colorectal cancer. Aberrant methylation levels were found in normal mucosa samples of SPS patients, and several genes showed significant differences in expression between SPS patients and healthy individuals. The hypermethylation of HLA-F was identified as a novel biomarker for SPS.

JOURNAL OF MOLECULAR DIAGNOSTICS (2022)

Article Oncology

LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer

Donatella Delle Cave, Silvia Buonaiuto, Bruno Sainz, Marco Fantuz, Maria Mangini, Alessandro Carrer, Annalisa Di Domenico, Tea Teresa Iavazzo, Gennaro Andolfi, Carme Cortina, Marta Sevillano, Christopher Heeschen, Vincenza Colonna, Marco Corona, Antonio Cucciardi, Martina Di Guida, Eduard Batlle, Annachiara De Luca, Enza Lonardo

Summary: This study identified a highly metastatic subpopulation of tumor-initiating cells marked by LAMC2 in pancreatic cancer. Targeting this LAMC2 population might be effective in reducing tumor aggressiveness.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Engineering, Biomedical

Modeling Biochemical Gradients In Vitro to Control Cell Compartmentalization in a Microengineered 3D Model of the Intestinal Epithelium

Gizem Altay, Aina Abad-Lazaro, Emilio J. Gualda, Jordi Folch, Claudia Insa, Sebastien Tosi, Xavier Hernando-Momblona, Eduard Batlle, Pablo Loza-Alvarez, Vanesa Fernandez-Majada, Elena Martinez

Summary: This study presents a novel 3D in vitro intestinal model based on primary epithelial cells that replicates both villus-like architecture and gradients of ISC biochemical factors. This model opens up possibilities for studying the nature of such gradients and resulting cellular responses in vitro.

ADVANCED HEALTHCARE MATERIALS (2022)

Article Oncology

MmCMS: mouse models' consensus molecular subtypes of colorectal cancer

Raheleh Amirkhah, Kathryn Gilroy, Sudhir B. B. Malla, Tamsin R. M. Lannagan, Ryan M. M. Byrne, Natalie C. C. Fisher, Shania M. M. Corry, Noha-Ehssan Mohamed, Hojjat Naderi-Meshkin, Megan L. L. Mills, Andrew D. D. Campbell, Rachel A. A. Ridgway, Baharak Ahmaderaghi, Richard Murray, Antoni Berenguer Llergo, Rebeca Sanz-Pamplona, Alberto Villanueva, Eduard Batlle, Ramon Salazar, Mark Lawler, Owen J. J. Sansom, Philip D. D. Dunne

Summary: In this study, three approaches for classifying human-to-mouse CRC tissue were developed, with MmCMS-C, a combined pathway system, showing the best accuracy in classifying epithelial-like subtypes (CMS2/3) of tumors. The results provide guidance for researchers to select suitable mouse models for studying human CRC subtypes.

BRITISH JOURNAL OF CANCER (2023)

Article Multidisciplinary Sciences

Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells

Adria Canellas-Socias, Carme Cortina, Xavier Hernando-Momblona, Sergio Palomo-Ponce, Eoghan J. Mulholland, Gemma Turon, Lidia Mateo, Sefora Conti, Olga Roman, Marta Sevillano, Felipe Slebe, Diana Stork, Adria Caballe-Mestres, Antonio Berenguer-Llergo, Adrian Alvarez-Varela, Nicola Fenderico, Laura Novellasdemunt, Laura Jimenez-Gracia, Tamara Sipka, Lidia Bardia, Patricia Lorden, Julien Colombelli, Holger Heyn, Xavier Trepat, Sabine Tejpar, Elena Sancho, Daniele V. F. Tauriello, Simon Leedham, Camille Stephan-Otto Attolini, Eduard Batlle

Summary: This study reveals the cell-state dynamics of residual disease in colorectal cancer and identifies the high-relapse cells responsible for relapse. Genetic ablation and immunotherapy targeting these cells can prevent metastatic recurrence and relapse after surgery.

NATURE (2022)

Article Multidisciplinary Sciences

Post-transcriptional control of a stemness signature by RNA-binding protein MEX3A regulates murine adult neurogenesis

Ana Domingo-Muelas, Pere Duart-Abadia, Jose Manuel Morante-Redolat, Antonio Jordan-Pla, German Belenguer, Jaime Fabra-Beser, Lucia Paniagua-Herranz, Ana Perez-Villalba, Adrian Alvarez-Varela, Francisco M. Barriga, Cristina Gil-Sanz, Felipe Ortega, Eduard Batlle, Isabel Farinas

Summary: In this article, the authors identified the RNA-binding protein MEX3A as a post-transcriptional regulator that controls quiescence and differentiation traits in the murine subependymal neurogenic lineage. They found that MEX3A regulates a set of stemness associated transcripts at critical transitions in this neurogenic lineage. This protein is crucial for the maintenance of neural stem cells and the repression of differentiation.

NATURE COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Antitumor T-cell function requires CPEB4-mediated adaptation to chronic endoplasmic reticulum stress

Marcos Fernandez-Alfara, Annarita Sibilio, Judit Martin, Elsa Tusquets Uxo, Marina Malumbres, Victor Alcalde, Veronica Chanes, Adria Canellas-Socias, Sergio Palomo-Ponce, Eduard Batlle, Raul Mendez

Summary: Tumor growth is influenced by complex interactions between multiple cell types in the tumor microenvironment. Chronic endoplasmic reticulum (ER) stress impairs the antitumor function of CD8 T lymphocytes. RNA-binding protein CPEB4 mediates adaptation to sustained ER stress in effector CD8 T lymphocytes, allowing them to maintain fitness and antitumor function.

EMBO JOURNAL (2023)

Article Chemistry, Medicinal

Peptide-Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells

Jenniffer Linares, Monica Varese, Anna Sallent-Aragay, Ana Mendez, Sergio Palomo-Ponce, Mar Iglesias, Eduard Batlle, Jorge Pisonero, Clara Montagut, Ernest Giralt, Daniele Lo Re, Alexandre Calon

Summary: We report the synthesis of a novel Pt(IV) cell-penetrating peptide conjugate, C-POC, with reduced impact on nonmalignant cells. In vitro and in vivo evaluation showed that C-POC maintains robust anticancer efficacy while reducing accumulation in healthy organs and adverse toxicity compared to standard Pt-based therapy. Our findings highlight the importance of considering the off-target impact of anticancer treatment on normal cells for improved drug development and patient care.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Mendez, Noemi Manero-Ruperez, Daniele Lo Re, Elisa I. Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adria Canellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez, Pilar Navarro, Josep Tabernero, Roger R. Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon

Summary: A significant number of colorectal cancer patients are not responsive to platinum-based chemotherapy due to drug resistance. In this study, researchers used elemental imaging to map the biodistribution of chemotherapy in residual tumors and analyzed the genetic changes induced by oxaliplatin-based chemotherapy in the tumor microenvironment. They found that oxaliplatin is retained by cancer-associated fibroblasts long after treatment, leading to increased activity of TGF-beta and production of factors that promote cancer aggressiveness. This study highlights the importance of chemotherapy-retaining cancer-associated fibroblasts in cancer progression and resistance to treatment.

NATURE COMMUNICATIONS (2023)

Article Oncology

Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy

Adrian Alvarez-Varela, Laura Novellasdemunt, Francisco M. Barriga, Xavier Hernando-Momblona, Adria Canellas-Socias, Sara Cano-Crespo, Marta Sevillano, Carme Cortina, Diana Stork, Clara Morral, Gemma Turon, Felipe Slebe, Laura Jimenez-Gracia, Ginevra Caratu, Peter Jung, Giorgio Stassi, Holger Heyn, Daniele V. F. Tauriello, Lidia Mateo, Sabine Tejpar, Elena Sancho, Camille Stephan-Otto Attolini, Eduard Batlle

Summary: Colorectal cancer stem cells can adapt to suboptimal niche environments, leading to chemoresistance and recurrence after treatment. These cells express the gene MEX3A and downregulate the WNT/Lgr5(+) stem cell gene program, adopting a transient regenerative state.

NATURE CANCER (2022)

Article Oncology

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR x LGR5 bispecific antibody with efficacy in epithelial tumors

Bram Herpers, Berina Eppink, Mark James, Carme Cortina, Adria Canellas-Socias, Sylvia F. Boj, Xavier Hernando-Momblona, Dominik Glodzik, Rob C. Roovers, Marc van de Wetering, Carina Bartelink-Clements, Vanessa Zondag-van der Zande, Jara Garcia Mateos, Kuan Yan, Lucia Salinaro, Abdul Basmeleh, Szabolcs Fatrai, David Maussang, Jeroen J. Lammerts van Bueren, Irene Chicote, Garazi Serna, Laia Cabellos, Lorena Ramirez, Paolo Nuciforo, Ramon Salazar, Cristina Santos, Alberto Villanueva, Camille Stephan-Otto Attolini, Elena Sancho, Hector G. Palmer, Josep Tabernero, Michael R. Stratton, John de Kruif, Ton Logtenberg, Hans Clevers, Leo S. Price, Robert G. J. Vries, Eduard Batlle, Mark Throsby

Summary: Researchers developed an organoid platform for functional antibody screening and identified a therapeutic bispecific antibody that showed efficacy in epithelial tumor models. The study demonstrated the potential of patient-derived organoids in supporting personalized medicine and highlighted the importance of functional screening in drug discovery.

NATURE CANCER (2022)

Review Oncology

Overcoming TGFβ-mediated immune evasion in cancer

Daniele V. F. Tauriello, Elena Sancho, Eduard Batlle

Summary: This review discusses the role of TGF beta in the tumour immune microenvironment and the importance of TGF beta inhibition in restoring cancer immunity. TGF beta controls multiple cell fate decisions during development and tissue homeostasis, and dysregulation of this pathway can lead to various diseases including cancer. The context-dependent functions of TGF beta in the tumour microenvironment play a crucial role in suppressing or promoting cancer.

NATURE REVIEWS CANCER (2022)

暂无数据